Press Releases
Company News
View Summary Medivation and Astellas Announce Enzalutamide (Formerly MDV3100) Data to Be Presented at ASCO Annual Meeting 2012
May 18, 2012
PDF 10.9 KB Add to Briefcase
View Summary Medivation Announces Participation at Upcoming Investor Conferences
May 11, 2012
PDF 8.0 KB Add to Briefcase
View Summary Medivation Reports First Quarter Financial Results and Provides Corporate Update
May 8, 2012
PDF 23.3 KB Add to Briefcase
View Summary Medivation Announces First Quarter 2012 Financial Results Teleconference on May 8, 2012
May 1, 2012
PDF 7.6 KB Add to Briefcase
View Summary Medivation Announces Poster Presentations at AACR Annual Meeting 2012
Mar 30, 2012
PDF 8.2 KB Add to Briefcase
View Summary Medivation, Inc. Closes 2.625% Convertible Senior Notes Due 2017
Mar 19, 2012
PDF 10.7 KB Add to Briefcase
View Summary Medivation, Inc. Prices $225 Million 2.625% Convertible Senior Notes Due 2017
Mar 13, 2012
PDF 11.4 KB Add to Briefcase
View Summary Medivation, Inc. to Offer $175 Million Convertible Senior Notes Due 2017
Mar 12, 2012
PDF 10.9 KB Add to Briefcase
View Summary Medivation Announces Participation at Upcoming Investor Conferences
Mar 2, 2012
PDF 7.8 KB Add to Briefcase
View Summary Medivation Reports Fourth Quarter and Year-End 2011 Financial Results and Provides Corporate Update
Feb 29, 2012
PDF 21.4 KB Add to Briefcase
View Summary Medivation Announces Fourth Quarter and Year-End Financial Results Teleconference on February 29, 2012
Feb 22, 2012
PDF 7.8 KB Add to Briefcase
View Summary Medivation Announces Participation at Upcoming Investor Conferences
Feb 10, 2012
PDF 7.9 KB Add to Briefcase
View Summary Medivation and Astellas Announce Positive Results From the Phase 3 AFFIRM Trial of MDV3100 in Prostate Cancer Patients Who Received Prior Chemotherapy
Jan 31, 2012
PDF 15.3 KB Add to Briefcase
View Summary Medivation and Pfizer Announce Results from Phase 3 Concert Trial of Dimebon in Alzheimer's Disease
Jan 17, 2012
PDF 11.7 KB Add to Briefcase
View Summary Data From Phase 3 AFFIRM Trial of MDV3100 in Advanced Prostate Cancer to Be Highlighted in Late-Breaking Presentation at ASCO GU
Jan 9, 2012
PDF 10.1 KB Add to Briefcase
View Summary Medivation Announces Participation at Upcoming Investor Conference
Dec 26, 2011
PDF 7.4 KB Add to Briefcase
View Summary Medivation Announces Participation at Three Upcoming Investor Conferences
Nov 23, 2011
PDF 7.8 KB Add to Briefcase
View Summary Medivation Names Sarah Noonberg Vice President of Clinical Development
Nov 17, 2011
PDF 7.8 KB Add to Briefcase
View Summary Medivation Reports Third Quarter 2011 Financial Results and Provides Corporate Update
Nov 9, 2011
PDF 22.0 KB Add to Briefcase
View Summary Medivation and Astellas Announce Positive Survival Data From Interim Analysis of Phase 3 AFFIRM Trial of MDV3100 in Men With Advanced Prostate Cancer
Nov 3, 2011
PDF 15.5 KB Add to Briefcase
Showing 81-100 of 304 Page: 1 2 3 4 5 6 7 8 9 ... 16  Previous 20 | Next 20
Add to Briefcase = add release to Briefcase

Top